EPFL Investor Day 2024

10 Dec 2024 | Lausanne, Switzerland

Soumya (Som) Banerjee

CEO and Co-founder

Juvion Life Sciences

Lausanne, Switzerland

34 profile visitsSpeaker

Using a novel platform and innovative research, we develop therapies to sustain mobility and delay sarcopenia with age.

My organisation

Juvion Life Sciences

Juvion Life Sciences

Startup

Lausanne, Switzerland

Age-related mobility decline and conditions like sarcopenia are often linked to the deterioration of neuron-muscle communication. Juvion Life Sciences (JLS), a spin-off from EPFL, has identified innovative biological mechanisms that preserve neuromuscular connections, maintaining the structure and function of motor circuitry. This breakthrough is pivotal, demonstrating for the first time that mobility decline can be mitigated. Building on this expertise, Juvion integrates cutting-edge, sustainable, first-in-class discovery platforms to develop safe and effective therapeutics aimed at stabilizing the motor system and combating mobility loss. Their mission is to make these solutions accessible to all aging individuals, addressing a critical societal challenge as the global population continues to grow older.
Read more

About me

My organisation

Juvion Life Sciences

Social media

Speaker sessions (1)

Tuesday, 10 December 2024

10:15 - 11:20

Pitch Sessions Healthtech

Location:Pitch Area 1Track:Pitch Session

Experience the forefront of healthtech innovation at EPFL Investor Day!